Updated lung cancer staging system

2009 ◽  
Vol 5 (10) ◽  
pp. 1545-1553 ◽  
Author(s):  
Ramon Rami-Porta ◽  
Kari Chansky ◽  
Peter Goldstraw
2009 ◽  
Vol 138 (2) ◽  
pp. 412-418.e2 ◽  
Author(s):  
Edmund S. Kassis ◽  
Ara A. Vaporciyan ◽  
Stephen G. Swisher ◽  
Arlene M. Correa ◽  
B. Nebiyou Bekele ◽  
...  

2012 ◽  
Vol 79 (5 e-suppl 1) ◽  
pp. S7-S10 ◽  
Author(s):  
Cristina P. Rodriguez

2017 ◽  
Vol 104 (6) ◽  
pp. 1829-1836 ◽  
Author(s):  
Andrew P. Dhanasopon ◽  
Michelle C. Salazar ◽  
Jessica R. Hoag ◽  
Joshua E. Rosen ◽  
Anthony W. Kim ◽  
...  

2012 ◽  
Vol 43 (5) ◽  
pp. 911-914 ◽  
Author(s):  
Juan J. Fibla ◽  
Stephen D. Cassivi ◽  
Paul A. Decker ◽  
Mark S. Allen ◽  
Gail E. Darling ◽  
...  

2018 ◽  
Vol 7 (2) ◽  
pp. 55-58
Author(s):  
Sandhya C. Acharya ◽  
A Karn

Background: Lung cancer is the leading cause of cancer related morbidity and mortality accounting for 15.4 % of total cancer in Nepal. With revision of the Lung cancer staging system by International Association for the Study of Lung Cancerand adoption of seventh edition of staging system by American Joint Committee on Cancer in 2010, the application of seventh edition of staging system has significant impact on stage of disease which ultimately defines treatment strategyand overall prognosis.Objective: To improve stage precision by adapting new staging system, this will directly refl ect on disease treatment, survival and prognosis.Methodology: Medical records of 151 patients with lung cancer attending Oncology Department, between 2015 and 2016 were retrospectively reclassified using both sixth and seventh editions of staging system. Data were collected compared and managed using Statistical Package for Social Sciences. Ethical clearance was obtained from Institutional Review Board.Results: Stage migration was seen in 15.23 % of total cases. Seven percent of cases staged down from IIIB to IIIA. Four percent were staged up from IIIB to IV. Remaining were down staged from T4 to T3 and T3 to T2 due to sub categorization of tumor by size in seventh edition.Conclusions: There was downstage from IIIB to IIIA and upstage from IIIB to IV because of revised staging system. Thus, it is essential to have detailed radiological staging and routine pleural fluid cytology before initiation of treatment, which will further help to stage accurately and treat properly. This carries direct impact on prognosis and survival. Journal of Kathmandu Medical College,Vol. 7, No. 2, Issue 24, Apr.-Jun., 2018, Page: 55-58


2007 ◽  
Vol 131 (7) ◽  
pp. 1016-1026
Author(s):  
Douglas B. Flieder

Abstract Context.—Lung cancer is the leading cause of cancer mortality worldwide. Despite technological, therapeutic, and scientific advances, most patients present with incurable disease and a poor chance of long-term survival. For those with potentially curable disease, lung cancer staging greatly influences therapeutic decisions. Therefore, surgical pathologists determine many facets of lung cancer patient care. Objective.—To present the current lung cancer staging system and examine the importance of mediastinal lymph node sampling, and also to discuss particularly confusing and/or challenging areas in lung cancer staging, including assessment of visceral pleura invasion, bronchial and carinal involvement, and the staging of synchronous carcinomas. Data Sources.—Published current and prior staging manuals from the American Joint Committee on Cancer and the International Union Against Cancer as well as selected articles pertaining to lung cancer staging and diagnosis accessible through PubMed (National Library of Medicine) form the basis of this review. Conclusions.—Proper lung cancer staging requires more than a superficial appreciation of the staging system. Clinically relevant specimen gross examination and histologic review depend on a thorough understanding of the staging guidelines. Common sense is also required when one is confronted with a tumor specimen that defies easy assignment to the TNM staging system.


2010 ◽  
Vol 2010 ◽  
pp. 5-7
Author(s):  
M.L. Rosado de Christenson

2010 ◽  
Vol 5 (3) ◽  
pp. 340-343 ◽  
Author(s):  
Chun-Ru Chien ◽  
Su-Tso Yang ◽  
Chih-Yi Chen ◽  
Hsin-Yuan Fang ◽  
Chih-Yen Tu ◽  
...  

1999 ◽  
Vol 8 (2) ◽  
pp. 231-244 ◽  
Author(s):  
Robert J. Burnett ◽  
Douglas E. Wood

Sign in / Sign up

Export Citation Format

Share Document